Leukeran 2 Glaxosmithkline

£235.00

Leukeran 2mg by GlaxoSmithKline is a pharmaceutical-grade chlorambucil preparation for advanced cancer cell research and cytotoxic mechanism studies in controlled laboratory environments.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Leukeran 2 Glaxosmithkline
Leukeran 2 Glaxosmithkline
£235.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Leukeran 2mg GlaxoSmithKline Research Overview

Leukeran 2mg is a pharmaceutical-grade chlorambucil preparation manufactured by GlaxoSmithKline, representing a nitrogen mustard alkylating agent extensively studied in oncological research. Chlorambucil functions as a bifunctional alkylating agent that forms covalent bonds with DNA, making it valuable for investigating cytotoxic mechanisms and cancer cell biology. Researchers examining DNA damage pathways, cellular apoptosis, and chemoresistance mechanisms frequently utilise this compound in their investigations. The pharmaceutical-grade formulation ensures consistent quality for laboratory applications requiring precise dosing and reliable reproducibility across experimental protocols.

When conducting research with compounds like Leukeran, investigators often examine complementary pathways studied with Stroid UK Shop or explore metabolic interactions with SARM research compounds. The chlorambucil mechanism provides insights into alkylating agent activity that researchers compare with peptide therapeutics in oncology studies.

Chlorambucil Research Applications

Laboratory studies evaluate chlorambucil’s mechanism of action in various cancer cell lines, particularly haematological malignancies. Research applications include DNA cross-linking studies, investigation of drug resistance mechanisms, and evaluation of combination therapeutic approaches. Scientists examine how chlorambucil affects cell cycle progression, induces apoptotic pathways, and interacts with cellular repair mechanisms. The compound’s oral bioavailability in preclinical models makes it valuable for pharmacokinetic studies and bioavailability research. Investigators studying chemotherapy resistance frequently analyse chlorambucil alongside other alkylating agents to understand cross-resistance patterns and identify potential therapeutic combinations. Chlorambucil research compounds enable comprehensive studies of nitrogen mustard pharmacology and cellular toxicity mechanisms.

Leukeran Specifications

Leukeran 2mg Product Specifications
Parameter Value
Active ingredient Chlorambucil
Strength 2mg per tablet
Manufacturer GlaxoSmithKline
CAS number 305-03-3
Molecular formula C₁₄H₁₉Cl₂NO₂
Molecular weight 304.21 g/mol
Storage conditions Room temperature, dry environment

Research Compliance Statement

Leukeran 2mg GlaxoSmithKline is supplied exclusively for qualified research purposes and in-vitro laboratory investigations. This pharmaceutical-grade compound is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must maintain appropriate laboratory safety protocols, proper storage conditions, and comprehensive documentation when handling this material. All studies should comply with institutional guidelines for hazardous substance research and appropriate waste disposal procedures for cytotoxic compounds.

Related